BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/26/2025 10:16:43 AM | Browse: 52 | Download: 395
 |
Received |
|
2024-11-07 11:01 |
|
Peer-Review Started |
|
2024-11-07 11:01 |
|
First Decision by Editorial Office Director |
|
2024-12-24 08:07 |
|
Return for Revision |
|
2024-12-24 08:45 |
|
Revised |
|
2025-01-18 23:09 |
|
Publication Fee Transferred |
|
2025-01-24 04:44 |
|
Second Decision by Editor |
|
2025-02-24 02:43 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-02-24 09:12 |
|
Articles in Press |
|
2025-02-24 09:12 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-03-15 03:18 |
|
Publish the Manuscript Online |
|
2025-03-26 10:16 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
Downregulation of huntingtin-associated protein 1 predicts poor prognosis in gastric cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiang-Yang Wang, Fu-Hai Yang, Zhong-Yuan Yuan, Zhong-Jing Wang, Hong-Feng Zhang and Zi-Hui Xu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Hubei Province Natural Science Foundation Project |
No. 2021CFB448 |
| Wuhan Municipal Health Commission |
No. WX23A55 |
|
| Corresponding Author |
Zi-Hui Xu, Associate Chief Physician, MD, PhD, Department of Endocrinology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, No. 26 Shengli Street, Wuhan 430014, Hubei Province, China. tj017@163.com |
| Key Words |
Huntingtin-associated protein 1; Gastric cancer; Prognostic utility; Biomarker; Clinical stage |
| Core Tip |
The clinical utility of huntingtin-associated protein 1 (HAP1) expression in gastric cancer (GC) was assessed. HAP1 expression was significantly lower in GC tissues than in normal gastric mucosa, and was strongly associated with GC progression and metastasis. Downregulation of HAP1 correlates with poor overall survival in patients with GC, especially in advanced clinical stages. Thus, HAP1 is a promising prognostic marker for GC, with important implications for advancing treatment. |
| Publish Date |
2025-03-26 10:16 |
| Citation |
Wang XY, Yang FH, Yuan ZY, Wang ZJ, Zhang HF, Xu ZH. Downregulation of huntingtin-associated protein 1 predicts poor prognosis in gastric cancer. World J Clin Oncol 2025; 16(4): 102958 |
| URL |
https://www.wjgnet.com/2218-4333/full/v16/i4/102958.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v16.i4.102958 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
